Stock Jumps 6% from Day’s Low After IHH Healthcare Plans to Increase Stake by 19%

Synopsis: Healthcare stock rallied after IHH Healthcare committed to raising its stake, signaling long-term backing, unlocking expansion plans, strengthening operations, and easing legacy concerns, which together could drive valuation upside and sustained investor interest.

One of India’s leading integrated healthcare service providers, operating a network of multi-specialty hospitals, diagnostic centers, and day-care facilities surged about 6.5% from days low, after a major shareholder’s announcement to increase its ownership stake from 31% to 50%. With a market cap of Rs. 62,624 Cr., the shares of Fortis Healthcare Ltd. surged about 6.5% from intraday low of Rs. 785 to Rs. 837 per share.

What’s the news

IHH Healthcare announced plans to increase its stake to 50% from 31%, signaling a strong vote of confidence in the Indian hospital operator’s long-term growth trajectory. The proposed stake hike is not merely a financial move but a strategic pivot that positions Fortis for accelerated expansion and operational transformation. Backed by IHH’s capital strength and global expertise, Fortis aims to add approximately 2,000 beds by 2028, enabling it to tap into rising healthcare demand across India’s tier-1 and tier-2 cities. 

This aggressive capacity expansion is expected to significantly enhance its market share in a rapidly growing healthcare sector. At the same time, IHH is driving a group-wide transformation focused on efficiency and sustainability, which will see Fortis adopt global best practices in clinical quality, cost optimization, and digital integration. These initiatives are likely to push operating margins toward a targeted 25%, marking a substantial improvement from levels seen during years of legal and governance challenges.

Importantly, the increase in stake also removes a long-standing legal overhang that had weighed on investor sentiment for nearly seven years. With greater ownership clarity and capital backing, Fortis is now being re-evaluated by the market as a stable and scalable healthcare platform rather than a distressed asset. 

About the company and Financial’s

Fortis Healthcare is one of India’s leading integrated healthcare service providers, operating a network of multi-specialty hospitals, diagnostic centers, and day-care facilities across the country. Founded in 1996, the company has built a strong presence in major metro cities like Delhi, Mumbai, Bengaluru, and Chennai, along with expanding footprints in tier-2 markets to capture growing healthcare demand. Fortis is known for offering advanced medical care across specialties such as cardiology, oncology, neurology, orthopedics, and organ transplants, supported by modern infrastructure and experienced medical professionals.

The company’s quarterly revenue rose from ₹1,928 Cr in December 2024 to ₹2,265 Cr in December 2025. This represents a solid 17.5% year-on-year increase in sales, driven by improved hospital occupancy and steady performance in its diagnostics vertical. While the net profit decreased from ₹254 Cr in December 2024 to ₹197 Cr in December 2025, its Operating Profit actually improved from ₹375 Cr to ₹506 Cr in the same period.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Stock Jumps 6% from Day’s Low After IHH Healthcare Plans to Increase Stake by 19% appeared first on Trade Brains.